Predictive Value of Clinical Judgment of Tumour Progression in Phase II Trials

od Kotecki, Nuria, Penel, Nicolas, Adenis, Antoine, Ferte, Charles, Clisant, Stéphanie
Izdano 2012

Frequency of Certain Established Risk Factors in Soft Tissue Sarcomas in Adults: A Prospective Descriptive Study of 658 Cases

od Penel, Nicolas, Grosjean, Jessica, Robin, Yves Marie, Vanseymortier, Luc, Clisant, Stéphanie, Adenis, Antoine
Izdano 2008

Improvement of the initial management of sarcomas after the dissemination of evidence-based guidelines depends on the primary sarcoma location: a population-based study

od Ligier, Karine, Maynou, Carlos, Leroy, Xavier, Robin, Yves-Marie, Martin, Philippe, Clisant, Stéphanie, Richard, Florence, Penel, Nicolas
izdano v BMC Cancer (2015)

Determinants of patient delay in doctor consultation in head and neck cancers (Protocol DEREDIA)

od Christophe, Véronique, Leroy, Tanguy, Seillier, Mélanie, Duthilleul, Camille, Julieron, Morbize, Clisant, Stéphanie, Foncel, Jérôme, Vallet, Fanny, Lefebvre, Jean-Louis
Izdano 2014

Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome

od Adenis, Antoine, Tresch, Emmanuelle, Dewas, Sylvain, Romano, Olivier, Messager, Mathieu, Amela, Eric, Clisant, Stéphanie, Kramar, Andrew, Mariette, Christophe, Mirabel, Xavier
Izdano 2013

Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care

od Penel, N, Clisant, S, Dansin, E, Desauw, C, Dégardin, M, Mortier, L, Vanhuyse, M, Bonodeau, F, Fournier, C, Cazin, J-L, Adenis, A
Izdano 2010

Impact of early palliative care on overall survival of patients with metastatic upper gastrointestinal cancers treated with first-line chemotherapy: a randomised phase III trial

od Hutt, Emilie, Da Silva, Arlette, Bogart, Emilie, Le Lay-Diomande, Sara, Pannier, Diane, Delaine-Clisant, Stéphanie, Le Deley, Marie-Cécile, Adenis, Antoine
izdano v BMJ Open (2018)

Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial

od Brodowicz, Thomas, Liegl-Atzwager, Bernadette, Tresch, Emmanuelle, Taieb, Sophie, Kramar, Andrew, Gruenwald, Viktor, Vanseymortier, Marie, Clisant, Stéphanie, Blay, Jean-Yves, Le Cesne, Axel, Penel, Nicolas
izdano v BMC Cancer (2015)

Circulating vascular endothelial growth factor (VEGF) as predictive factor of progression-free survival in patients with advanced chordoma receiving sorafenib: an analysis from a p...

od Lebellec, Loic, Bertucci, François, Tresch-Bruneel, Emmanuelle, Bompas, Emmanuelle, Toiron, Yves, Camoin, Luc, Mir, Olivier, Laurence, Valerie, Clisant, Stephanie, Decoupigny, Emilie, Blay, Jean-Yves, Goncalves, Anthony, Penel, Nicolas
izdano v Oncotarget (2016)

Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial

od Pannier, Diane, Adenis, Antoine, Bogart, Emilie, Dansin, Eric, Clisant-Delaine, Stéphanie, Decoupigny, Emilie, Lesoin, Anne, Amela, Eric, Ducornet, Sandrine, Meurant, Jean-Pierre, Le Deley, Marie-Cécile, Penel, Nicolas
izdano v BMC Cancer (2018)

The FREGAT biobank: a clinico-biological database dedicated to esophageal and gastric cancers

od Mariette, Christophe, Renaud, Florence, Piessen, Guillaume, Gele, Patrick, Copin, Marie-Christine, Leteurtre, Emmanuelle, Delaeter, Christine, Dib, Malek, Clisant, Stéphanie, Harter, Valentin, Bonnetain, Franck, Duhamel, Alain, Christophe, Véronique, Adenis, Antoine
izdano v BMC Cancer (2018)

A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted olid tumours

od Adenis, A, Ray-Coquard, I, Italiano, A, Chauzit, E, Bui-Nguyen, B, Blay, J-Y, Tresch-Bruneel, E, Fournier, C, Clisant, S, Amela, E Y, Cassier, P A, Molimard, M, Penel, N
Izdano 2013

Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter stu...

od Adenis, Antoine, de la Fouchardiere, Christelle, Paule, Bernard, Burtin, Pascal, Tougeron, David, Wallet, Jennifer, Dourthe, Louis-Marie, Etienne, Pierre-Luc, Mineur, Laurent, Clisant, Stéphanie, Phelip, Jean-Marc, Kramar, Andrew, Andre, Thierry
izdano v BMC Cancer (2016)

Erratum to: Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a mul...

od Adenis, Antoine, de la Fouchardiere, Christelle, Paule, Bernard, Burtin, Pascal, Tougeron, David, Wallet, Jennifer, Dourthe, Louis-Marie, Etienne, Pierre-Luc, Mineur, Laurent, Clisant, Stéphanie, Phelip, Jean-Marc, Kramar, Andrew, Andre, Thierry
izdano v BMC Cancer (2016)

Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin—folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, ra...

od Messager, Mathieu, Mirabel, Xavier, Tresch, Emmanuelle, Paumier, Amaury, Vendrely, Véronique, Dahan, Laetitia, Glehen, Olivier, Vasseur, Frederique, Lacornerie, Thomas, Piessen, Guillaume, El Hajbi, Farid, Robb, William B., Clisant, Stéphanie, Kramar, Andrew, Mariette, Christophe, Adenis, Antoine
izdano v BMC Cancer (2016)

Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)(†)

od Bompas, E., Le Cesne, A., Tresch-Bruneel, E., Lebellec, L., Laurence, V., Collard, O., Saada-Bouzid, E., Isambert, N., Blay, J. Y., Amela, E. Y., Salas, S., Chevreau, C., Bertucci, F., Italiano, A., Clisant, S., Penel, N.
izdano v Ann Oncol (2015)

REGOSARC: Regorafenib versus placebo in doxorubicin‐refractory soft‐tissue sarcoma—A quality‐adjusted time without symptoms of progression or toxicity analysis

od Berry, Vincent, Basson, Laurent, Bogart, Emilie, Mir, Olivier, Blay, Jean‐Yves, Italiano, Antoine, Bertucci, François, Chevreau, Christine, Clisant‐Delaine, Stéphanie, Liegl‐Antzager, Bernadette, Tresch‐Bruneel, Emmanuelle, Wallet, Jennifer, Taieb, Sophie, Decoupigny, Emilie, Le Cesne, Axel, Brodowicz, Thomas, Penel, Nicolas
izdano v Cancer (2017)

Sorafenib for Patients with Advanced Angiosarcoma: A Phase II Trial from the French Sarcoma Group (GSF/GETO)

od Ray-Coquard, Isabelle, Italiano, Antoine, Bompas, Emmanuelle, Le Cesne, Axel, Robin, Yves-Marie, Chevreau, Christine, Bay, Jacques-Olivier, Bousquet, Guilhem, Piperno-Neumann, Sophie, Isambert, Nicolas, Lemaitre, Laurent, Fournier, Charles, Gauthier, Eric, Collard, Olivier, Cupissol, Didier, Clisant, Stéphanie, Blay, Jean-Yves, Penel, Nicolas
Izdano 2012

The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME)

od Pérol, David, Robain, Mathieu, Arveux, Patrick, Mathoulin-Pélissier, Simone, Chamorey, Emmanuel, Asselain, Bernard, Berchery, Delphine, Gourgou, Sophie, Breton, Mathias, Delaine-Clisant, Stéphanie, Mons, Muriel, Diéras, Véronique, Carton, Matthieu, Guizard, Anne-Valérie, Laborde, Lilian, Laurent, Carine, Loeb, Agnès, Mouret-Reynier, Marie-Ange, Parent, Damien, Perrocheau, Geneviève, Campion, Loïc, Velten, Michel, Cailliot, Christian, Ezzalfani, Monia, Simon, Gaëtane
izdano v BMJ Open (2019)